Literature DB >> 22358907

The economic production of anti-microbial factor from human promyelocytes in low serum containing medium under chemostat cultivation.

Y N Kim1, H G Kim, S K Lim, K Y Park, J S Park, H Murakami, H Y Lee.   

Abstract

It proves that a purifed Anti-Microbial Factor (AMF) from human promyelocytes has strong activity on Gram(-) and Gram(+) bacteria, showing 0.5 (μg/ml) of Minimal Bacterical Concentration (MBC) on bothE. coli andS. aureus. For mass production of AMF, chemostat cultivation is recommended to accumulate cells out of the reactor since it is an intracellular protein and its system requires only 1% serum in the medium. Its production process proves to be closely growth-related. 1.7×10(-8) (μg/viable cell/day) of maximum specific AMF production rate is estimated at 0.026 h(-1) of dilution rate, maintaining 6×10(6) (viable cell/ml). Ca. 300 (mg/ml) of crude AMF can be obtained for 50 days of continuous cultivation under optimal conditions. The cell growth reaches relatively fast steady state.

Entities:  

Year:  1995        PMID: 22358907     DOI: 10.1007/BF00749757

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  13 in total

1.  Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes.

Authors:  J Weiss; P Elsbach; I Olsson; H Odeberg
Journal:  J Biol Chem       Date:  1978-04-25       Impact factor: 5.157

2.  Cloning and expression of the human erythropoietin gene.

Authors:  F K Lin; S Suggs; C H Lin; J K Browne; R Smalling; J C Egrie; K K Chen; G M Fox; F Martin; Z Stabinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

3.  Long-term culture of primary rat hepatocytes with high albumin secretion using membrane-supported collagen sandwich.

Authors:  M Suzuki; K Ichikawa; A Sakoda; Y Sakai
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

4.  A novel ultrasonic resonance field device for the retention of animal cells.

Authors:  O Doblhoff-Dier; T Gaida; H Katinger; W Burger; M Gröschl; E Benes
Journal:  Biotechnol Prog       Date:  1994 Jul-Aug

5.  Phase separation of integral membrane proteins in Triton X-114 solution.

Authors:  C Bordier
Journal:  J Biol Chem       Date:  1981-02-25       Impact factor: 5.157

6.  Thrombospondin and fibronectin are synthesized by neutrophils in human inflammatory joint disease and in a rabbit model of in vivo neutrophil activation.

Authors:  C Kreis; M La Fleur; C Ménard; R Paquin; A D Beaulieu
Journal:  J Immunol       Date:  1989-09-15       Impact factor: 5.422

7.  Mammalian cell retention in a spinfilter perfusion bioreactor.

Authors:  V M Yabannavar; V Singh; N V Connelly
Journal:  Biotechnol Bioeng       Date:  1992-10-20       Impact factor: 4.530

8.  An in vitro amplification approach for the expression of recombinant proteins in mammalian cells.

Authors:  L Monaco; R Tagliabue; M R Soria; M Uhlèn
Journal:  Biotechnol Appl Biochem       Date:  1994-10       Impact factor: 2.431

9.  A kinetic model of the circulatory regulation of tissue plasminogen activator.

Authors:  W L Chandler
Journal:  Thromb Haemost       Date:  1991-09-02       Impact factor: 5.249

10.  Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation.

Authors:  N Borregaard; J M Heiple; E R Simons; R A Clark
Journal:  J Cell Biol       Date:  1983-07       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.